Revolution Medicines schedules call on pancreatic cancer trial results

Go back to Revolution Medicines schedules call on pancreatic cancer trial results
(NASDAQ: RVMD) Delayed: 169.77 +0.26 (0.15%)
Previous Close $169.51    52 Week High
Open $170.50    52 Week Low
Day High $170.65    P/E N/A 
Day Low $166.43    EPS
Volume 3,626,043